Kim, Mi-Kyung <br/><br/>
PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.  [electronic resource] 

 -  Archives of pharmacal research  May 2009 
 - 721-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0253-6269 
<br/><br/><label>Standard No.: </label>10.1007/s12272-009-1511-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipogenesis--drug effects<br/>Administration, Oral<br/>Animals<br/>Blood Glucose--drug effects<br/>Blood Volume--drug effects<br/>Cells, Cultured<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Partial Agonism<br/>Genes, Reporter<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Isoxazoles--administration & dosage<br/>Male<br/>Mesenchymal Stem Cells--drug effects<br/>Mice<br/>Mice, Inbred ICR<br/>PPAR gamma--agonists<br/>Propionates--administration & dosage<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology<br/>Thiophenes--administration & dosage<br/>Transfection<br/>Water-Electrolyte Balance--drug effects